Lexaria Bioscience Stock Forecast
NASDAQ: LEXXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LEXX analyst consensus
Consensus
none
Avg. price target
$82.50+2384.94%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
The average 12-month price target is $82.50, with a high estimate of $82.50 and a low estimate of $82.50. The average target implies upside of 2384.9% from the current price of $3.32. The spread between the highest and lowest targets is 0.0%, a relatively narrow range.
Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for LEXX.
Summary generated from market data by MetaCap's automated system. Methodology
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $82.50 | +2384.94% |
| Average target | $82.50 | +2384.94% |
| High target | $82.50 | +2384.94% |